Cic edizioni internazionali
Clinical Dermatology

Frontal fibrosing alopecia: when the treatment is worse than the disease

Case-Based review, 60 - 63
doi: 10.11138/cderm/2017.5.1.060
Tag this article
Abstract
Full text PDF
Frontal Fibrosing Alopecia (FFA) is a type of primary lymphocytic scarring alopecia, clinically characterized by a distinctive pattern of progressive frontotemporal hairline recession and eyebrow loss.
The etiopathogenesis of FFA is unknown, but it is widely considered a variant of lichen plano-pilaris usually, but not exclusively, affecting postmeno - pausal women. Current treatment aim to stop the disease progression, but no standardized treatment are recommended, and best results from observational studies have been reported for 5- reductase inhibitors and intralesional corticosteroids, followed by antimalarials and calcineurin inhibitors.
Here, we report a 52-year-old postmenopausal woman with a 7-year history of FFA, who experienced a severe worsening after treatment with intralesional triamcinolone acetonide, for the occurrence of steroid induced skin atrophy. Whether the physician has undervalued the well-known side effect of intralesional steroids or the peculiar fibrosing tendency of the disease has played a role is difficult to assess. No previous report of steroid induced atrophy in FFA was retrieved from the current literature. This case draws attention on the importance to properly estimate the consequences of medical interventions in disorders with exclusive aesthetic impact.

Vol. 5 (No. 1) 2017 January - March

  1. Unmet needs in hidradenitis suppurativa: patients’ perspective on daily management and cosmetic cares
    Atzori L., Pintori G., Patta F., Pinn A.L., Rongioletti F.
    doi: 10.11138/cderm/2017.5.1.001
  2. EP2311454 treatment for atopic dermatitis: therapeutic efficiency in patients and anti-inflammatory in vitro
    Umbert I., Sans G., Valls J., Márquez L., Costales P., Fernández L.
    doi: 10.11138/cderm/2017.5.1.005
  3. Cutaneous leishmaniasis and its clinical spectrum. An overview from the Old World
    Dassoni F.
    doi: 10.11138/cderm/2017.5.1.012
  4. Systemic immunosuppressive treatment in adult patients with atopic dermatitis: current and new treatment options
    van der Schaft J., Thijs J.L., Hijnen D., de Bruin-Weller M.S.
    doi: 10.11138/cderm/2017.5.1.022
  5. Possible role of mast cells and IL-37 in the pathogenesis of psoriasis
    Conti P., Caraffa A., Spinas E., Lessiani G., Kritas S.K., Ronconi G., Theoharides T.C.
    doi: 10.11138/cderm/2017.5.1.030
  6. Commentary on dermoscopy in general dermatology
    Russo T., Piccolo V., Agozzino M., Moscarella E., Lallas A., Argenziano G.
    doi: 10.11138/cderm/2017.5.1.037
  7. Gluten related disorders: even a dermatological issue
    Bonciolini V., Caproni M.
    doi: 10.11138/cderm/2017.5.1.043
  8. Congenital mastocytosis
    Virdi A., Neri I., Gurioli C., Patrizi A.
    doi: 10.11138/cderm/2017.5.1.048
  9. Frontal fibrosing alopecia: when the treatment is worse than the disease
    Lai M., Brundu M.A., Atzori L.
    doi: 10.11138/cderm/2017.5.1.060
Last Viewed articles: la lista degli ultimi x visitati.
  1. Frontal fibrosing alopecia: when the treatment is worse than the disease
    Lai M., Brundu M.A., Atzori L.
    doi: 10.11138/cderm/2017.5.1.060
credits